News in the Life Sciences Industry

SAINT CLOUD, France, October 26, 2018 /PRNewswire/ --

BERLIN, and BEIJING, and NEW HAVEN, Conn., Oct. 25, 2018 /PRNewswire-iReach/ -- Life Molecular Imaging (LMI) and XingImaging announced today that production of LMI's (18)F-labeled Tau PET imaging agent PI-2620 has commenced at XingImaging sites in China.

ZWEIBRUCKEN, Germany, Oct. 24, 2018 /PRNewswire/ -- The RAM Group announced today its Quantum Cardio-Respiratory Monitor (qCRM(TM)), the first-of-its-kind integrated single-point, non-invasive, bio-electro-mechanical sensor with the potential to provide full-body diagnostics and analysis. RAM... Read more ››

KALISPELL, Mont., Oct. 24, 2018 /PRNewswire/ -- ClassOne Technology, the premier supplier of new wet process tools to the 200mm and below semiconductor manufacturing industry, today announced the sale of its flagship Solstice® S8 wet process tool to the Ferdinand-Braun-Institute (FBH) in Berlin,... Read more ››

BURGWEDEL, Germany, Oct. 23, 2018 /PRNewswire/ -- MYR Pharma today announced that US Food and Drug Administration (FDA) has granted the Breakthrough Therapy designation for its lead compound Myrcludex. The designation is granted in the indication chronic hepatitis delta (HDV) infection. The designation... Read more ››

ZEISS to enhance its portfolio of Surgical Ophthalmology solutions, further positioning the Company as a global innovation leader and solution provider in the full space of ophthalmology

MARLBOROUGH, Mass., Oct. 23, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the District Court of Dusseldorf, Germany has determined that Edwards Lifesciences Corporation's Sapien 3 Ultra((TM)) device infringed a patent - established by Symetis SA, a subsidiary... Read more ››

CAMBRIDGE, Mass., Oct. 22, 2018 /PRNewswire/ -- GNS Healthcare (GNS), a leading precision medicine company, presented results in metastatic colorectal cancer this week from their most recent collaboration with the Alliance for... Read more ››

AMSTERDAM, October 22, 2018 /PRNewswire/ --

- Further demonstrates the test's ability to change clinical chemotherapy treatment decisions by more precisely identifying patients who will or will not benefit from chemotherapy hence targeting treatment more effectively

DARMSTADT, Germany, Oct. 22, 2018/PRNewswire/ --

AMSTERDAM, October 22, 2018 /PRNewswire/ --

VIENNA, October 22, 2018 /PRNewswire/ --

LEXINGTON, Mass., Oct. 20, 2018 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies, cancer vaccines, and adoptive cell therapies(2), presented updated clinical data on its lead CTLA-4 and PD-1 programs today at the 2018... Read more ››